| dbo:abstract
|
- Mary Broadfoot Walker, M.D. (17 April 1888 – 13 September 1974) was a Scottish physician who first demonstrated the effectiveness of physostigmine in the treatment of the condition myasthenia gravis, a disease relating to muscle weakness. She was also the first to recognise the association between familial periodic paralysis and low blood potassium levels. (en)
- Mary Broadfoot Walker, née à Croft-an-Righ, près de Wigtown en Écosse en 1888 et morte en 1974, est une femme médecin britannique à qui l'on doit la démonstration de l'efficacité de la physostigmine dans le traitement de la myasthénie, ainsi que d'une hypokaliémie dans la maladie de Westphal, lui permettant de traiter les crises de paralysie par le potassium. (fr)
|
| dbo:activeYearsEndYear
| |
| dbo:activeYearsStartYear
| |
| dbo:birthDate
| |
| dbo:birthPlace
| |
| dbo:deathDate
| |
| dbo:education
| |
| dbo:institution
| |
| dbo:knownFor
| |
| dbo:profession
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 7984 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:alt
| |
| dbp:birthDate
| |
| dbp:birthPlace
|
- Croft-an-Righ, Wigtown, Scotland (en)
|
| dbp:caption
| |
| dbp:deathDate
| |
| dbp:education
| |
| dbp:knownFor
|
- Treatment of myasthenia gravis with physostigmine (en)
- Association of familial periodic paralysis and hypokalaemia (en)
|
| dbp:name
|
- Dr. Mary Broadfoot Walker (en)
|
| dbp:prizes
|
- Royal College of Physicians Jean Hunter Prize (en)
|
| dbp:profession
| |
| dbp:researchField
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:workInstitutions
|
- dbr:Princess_Royal_Maternity_Hospital
- St Alfege's Hospital, Greenwich (en)
- St Benedict's Hospital, Tooting (en)
- St Francis' Hospital, Dulwich (en)
- St Leonard's Hospital, Shoreditch (en)
|
| dbp:yearsActive
| |
| dcterms:subject
| |
| gold:hypernym
| |
| rdf:type
| |
| rdfs:comment
|
- Mary Broadfoot Walker, M.D. (17 April 1888 – 13 September 1974) was a Scottish physician who first demonstrated the effectiveness of physostigmine in the treatment of the condition myasthenia gravis, a disease relating to muscle weakness. She was also the first to recognise the association between familial periodic paralysis and low blood potassium levels. (en)
- Mary Broadfoot Walker, née à Croft-an-Righ, près de Wigtown en Écosse en 1888 et morte en 1974, est une femme médecin britannique à qui l'on doit la démonstration de l'efficacité de la physostigmine dans le traitement de la myasthénie, ainsi que d'une hypokaliémie dans la maladie de Westphal, lui permettant de traiter les crises de paralysie par le potassium. (fr)
|
| rdfs:label
|
- Mary Walker (fr)
- Mary Broadfoot Walker (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
|
- Dr. Mary Broadfoot Walker (en)
|
| is dbo:wikiPageWikiLink
of | |
| is dbp:name
of | |
| is foaf:primaryTopic
of | |
